These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 26501979)

  • 1. Intrathecal Analgesia for Chronic Refractory Pain: Current and Future Prospects.
    Smyth C; Ahmadzai N; Wentzell J; Pardoe A; Tse A; Nguyen T; Goddard Y; Nair S; Poulin PA; Skidmore B; Ansari MT
    Drugs; 2015 Nov; 75(17):1957-80. PubMed ID: 26501979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal therapy for cancer and non-cancer pain.
    Hayek SM; Deer TR; Pope JE; Panchal SJ; Patel VB
    Pain Physician; 2011; 14(3):219-48. PubMed ID: 21587327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive consensus based guidelines on intrathecal drug delivery systems in the treatment of pain caused by cancer pain.
    Deer TR; Smith HS; Burton AW; Pope JE; Doleys DM; Levy RM; Staats PS; Wallace MS; Webster LR; Rauck RL; Cousins M;
    Pain Physician; 2011; 14(3):E283-312. PubMed ID: 21587338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal Drug Delivery for Chronic Pain Syndromes: A Review of Considerations in Practice Management.
    Abd-Elsayed A; Karri J; Michael A; Bryce D; Sun J; Lee M; Orhurhu V; Deer T
    Pain Physician; 2020 Nov; 23(6):E591-E617. PubMed ID: 33185379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in intrathecal drug delivery.
    Lawson EF; Wallace MS
    Curr Opin Anaesthesiol; 2012 Oct; 25(5):572-6. PubMed ID: 22825049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrathecal drug delivery system (IDDS) for cancer pain management: a review and updates.
    Upadhyay SP; Mallick PN
    Am J Hosp Palliat Care; 2012 Aug; 29(5):388-98. PubMed ID: 22089523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal drug delivery for pain management: recent advances and future developments.
    Jain S; Malinowski M; Chopra P; Varshney V; Deer TR
    Expert Opin Drug Deliv; 2019 Aug; 16(8):815-822. PubMed ID: 31305165
    [No Abstract]   [Full Text] [Related]  

  • 8. Advances in intrathecal drug delivery.
    De Andres J; Asensio-Samper JM; Fabregat-Cid G
    Curr Opin Anaesthesiol; 2013 Oct; 26(5):594-9. PubMed ID: 23816978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of intrathecal drug delivery system for refractory cancer pain patients: a single tertiary medical center experience.
    Lin CP; Lin WY; Lin FS; Lee YS; Jeng CS; Sun WZ
    J Formos Med Assoc; 2012 May; 111(5):253-7. PubMed ID: 22656395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal Drug Delivery Systems for Noncancer Pain: A Health Technology Assessment.
    Health Quality Ontario
    Ont Health Technol Assess Ser; 2016; 16(2):1-77. PubMed ID: 27026797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Best practices for intrathecal drug delivery for pain.
    Prager J; Deer T; Levy R; Bruel B; Buchser E; Caraway D; Cousins M; Jacobs M; McGlothlen G; Rauck R; Staats P; Stearns L
    Neuromodulation; 2014 Jun; 17(4):354-72; discussion 372. PubMed ID: 24446870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Intrathecal Analgesia With a Wireless Analgesia Pump System in the Home Care of Patients With Advanced Cancer.
    Liu HJ; Li WY; Chen HF; Cheng ZQ; Jin Y
    Am J Hosp Palliat Care; 2017 Mar; 34(2):148-153. PubMed ID: 26537661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal catheter-syringe adaptor for short-term intrathecal analgesia with an externalized pump: a case report.
    Wilkes D; Cook M; Solanki D
    Pain Physician; 2010; 13(2):151-6. PubMed ID: 20309381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory failure following delayed intrathecal morphine pump refill: a valuable, but costly lesson.
    Ruan X; Couch JP; Liu H; Shah RV; Wang F; Chiravuri S
    Pain Physician; 2010; 13(4):337-41. PubMed ID: 20648202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal Drug Delivery Systems for Refractory Pancreatic Cancer Pain: Observational Follow-up Study Over an 11-Year Period in a Comprehensive Cancer Center.
    Carvajal G; Dupoiron D; Seegers V; Lebrec N; Boré F; Dubois PY; Leblanc D; Delorme T; Jubier-Hamon S
    Anesth Analg; 2018 Jun; 126(6):2038-2046. PubMed ID: 29543644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrathecal Pain Therapy for the Management of Chronic Noncancer Pain.
    Sukul VV
    Neurosurg Clin N Am; 2019 Apr; 30(2):195-201. PubMed ID: 30898270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pain management, including intrathecal pumps.
    Smith TJ; Swainey C; Coyne PJ
    Curr Oncol Rep; 2004 Jul; 6(4):291-6. PubMed ID: 15161583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial.
    Staats PS; Yearwood T; Charapata SG; Presley RW; Wallace MS; Byas-Smith M; Fisher R; Bryce DA; Mangieri EA; Luther RR; Mayo M; McGuire D; Ellis D
    JAMA; 2004 Jan; 291(1):63-70. PubMed ID: 14709577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrathecal ziconotide and opioid combination therapy for noncancer pain: an observational study.
    Deer TR; Kim C; Bowman R; Tolentino D; Stewart C; Tolentino W
    Pain Physician; 2009; 12(4):E291-6. PubMed ID: 19668287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Polyanalgesic Consensus Conference (PACC): Recommendations for Intrathecal Drug Delivery: Guidance for Improving Safety and Mitigating Risks.
    Deer TR; Pope JE; Hayek SM; Lamer TJ; Veizi IE; Erdek M; Wallace MS; Grider JS; Levy RM; Prager J; Rosen SM; Saulino M; Yaksh TL; De Andrés JA; Abejon Gonzalez D; Vesper J; Schu S; Simpson B; Mekhail N
    Neuromodulation; 2017 Feb; 20(2):155-176. PubMed ID: 28042914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.